9999999997-17-003134.txt : 20170315
9999999997-17-003134.hdr.sgml : 20170315
20170315132152
ACCESSION NUMBER: 9999999997-17-003134
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20170315
DATE AS OF CHANGE: 20170315
20170202
20170315
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp
CENTRAL INDEX KEY: 0000921114
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911549568
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23930
FILM NUMBER: 17690700
BUSINESS ADDRESS:
STREET 1: 3579 VALLEY CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 804-827-2524
MAIL ADDRESS:
STREET 1: 3579 VALLEY CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/
DATE OF NAME CHANGE: 19940331
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-"B6UM;6U#0HQ(# @;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V4O4&%R96YT(#(@,"!2+U)E%L@," P(#8Q,B W
M.3)=("]#;VYT96YT)R565MOVDH0?H^4_[#2>;&EL/5>?#MO"9 T59L<)52JU!X=03#!
MDK$IF%[^_9D9V\!"M]ZV$N'R[77=],+B_>W HF))LL+B\$"^"_8#),
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M%N2F)E:J5-ED*Q'Q\,0.>]E(S[ V.Y147,>.RM@7-P]!<
MID,;.(K.P)'5*7%R!CXU_LVM/&M^.N !+(L%%TF[[+]?_K/JE<2_8P$VIZ6@
M2VH6AI!CKEBM<%L]]0Z"$4@3>[U:=XD*+TM,TO H1_?Y:4T5R=/83;V$WGF*
M'6(5@UR'FE%MIG[LU62,->5E"O."D)>:0%&P;B#-M'2IEB?6ZPFPRB^W5'9$)W:6P J?>*'9 U
MGL7??N"7=59NH>RS:@&_1!Y;T^)O>;7;-KVR6PAC4]2$I4;P"W"W(K$+_"&?
M9V6=3PM6P_JP"=2JJ^"P8D%-AN7EHNT]REM-:U1,X:S[MB="G%V;[>UM1TH4
MNSDP:P$Z-]6*UEG2UH"IV-EBEOFLQQV7EOS3@;8?XTUUCR >GV*K2LV
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MN,+)I]\>'UBZ?A;^1=$>6P
MSHUP@]\:WU(%QV4+-OQ5>-GM?OO=5+TD(O=M4$>'#"3/U.3<%M=[-#MRY^^J(];\[S[4M1;3.6UYSAE@=-@,C6>5Y2):$V4]C(K>#,G)H&
M449=H7SH9[:QR\B02*M:.GL2+DMC-D7B'< +=KK,72&6L
M?_._K1-C@ W3247'4SB&]A;U#AN$SD<>-VPDW;%I@N=! SO^@86UF]R8"'AD
M:ZQXLE-NFF00PL/5R4^U>Z1;&?M:!@\;)LA$>,I#(OY^L,"NDL/(Q
M(#ZZF(YT%([0)'*%ME11<":*':GBAFVHXH9MJ&)@SZEBNYUMJ>*DJ:6*$[:E
MBH%UIXJQ[!U5S1TU7B84738GMM@)A0GN9&(7O)B."F[82..5NUN@C[$XBARJ
M^;"B2X)FH-ANV[9[=3PRUY0-37,8P<1#!]/VS K3SKJYO[1>;U&9,RRP3T57
MT'TVVQTVJ'(_U/3X ;))=9+G38/#A*9IAD8)/&D-FH/#KEY6&[P0@5,!;+_IAH7#6.R*Q0=&CEB)#VL<2>&&;;+?#=MDOQ-6PFG%&=OD
MNA.VS74#BZ=&.B,"I=Y1Z'G#O*R8V^8+%8<\3O],)SY5ZK#/':.QIY#R>HHD
MA%.JB.Q/OT+!M3(E]447!E+U1R=654>7!E+TYA;64O1C(O0F%S949O;G0O5&EM
M97,C,C!.977!E+UA2968O4VEZ92 Q,B]76R Q
M(#0@,ET@+U)O;W0@,2 P(%(O26YF;R Y(# @4B])1%L\,#DV-T0T13!"1$4V
M0S T-SA#.3)!-S@R,4)!.3@X,#4^/# Y-C=$-$4P0D1%-D,P-#')E9@T*
M," Q,PT*,# P,# P,# P," V-34S-2!F#0HP,# P,# P,#$W(# P,# P(&X-
M"C P,# P,# P-S@@,# P,# @;@T*,# P,# P,#$S-" P,# P,"!N#0HP,# P
M,# P,S4W(# P,# P(&X-"C P,# P,#(S-34@,# P,# @;@T*,# P,# P,C4S
M,R P,# P,"!N#0HP,# P,# R-S')E9@T*-#(V.0T*)25%
M3T8-"GAR968-"C @, T*=')A:6QE<@T*/#PO4VEZ92 Q,R]2;V]T(#$@,"!2
M+TEN9F\@.2 P(%(O241;/# Y-C=$-$4P0D1%-D,P-#')E9@T*-#8X- T*)25%3T8!
end